# OnCo record nct04581473 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04581473/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04581473", "NCT04581473" ;
  schema:name "CT041-ST-01"@en ;
  schema:alternateName "CT041 ST-01"@en, "satri-cel CT041-ST-01"@en, "Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection"@en ;
  schema:description "The Chinese randomised trial in which Claudin 18.2 CAR-T cells delayed progression compared with the doctor's choice of later-line drugs in stomach cancer, the first randomised trial of CAR-T cells in a solid tumour."@en ;
  schema:url <https://onco.cc/trials/nct04581473/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04581473>, <https://doi.org/10.1016/S0140-6736(25)00860-8> ;
  onco:status "positive" ;
  onco:tag "china" ;
  onco:phase "1/2" ;
  schema:startDate "2020-10-23" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/gastric-cldn18-2-positive/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:drugs <https://onco.cc/drugs/satricabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/carsgen/> ;
  onco:institutions <https://onco.cc/institutions/pku-cancer-hospital/> ;
  onco:people <https://onco.cc/people/qi-changsong/>, <https://onco.cc/people/shen-lin/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ct041-st-01-lancet-2025/> .